Skip to main content

Table 2 Indications to MR Treatment by MitraClip System

From: Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review

CLINICAL INDICATIONS CLINICAL CONTRAINDICATIONS ECHOCARDIOGRAPHIC INDICATIONS ECHOCARDIOGRAPHIC CONTRAINDICATIONS
MR 3+ or 4+
and Symptoms
or/and
New Atrial Fibrillation
Recent Myocardial Infarction
Recent Surgical Procedure
Renal Insufficiency
Endocarditis
Rheumatic Heart Disease
MR 3+ or 4+
Compromised Left Ventricular Function (EF < 60% or End-Systolic Diameter ≥ 40 mm)
Pulmonary Hypertension
A Regurgitant Jet Origin at Level of Coaptation Zone
Coaptation Length ≥ 2 mm
Coaptation Depth ≤ 11 mm
Flail Gap < 10 mm
Flail Width < 15 mm
Left Ventricular EF < 25%
Left Ventricular End-Systolic Diameter > 55 mm
Mitral Valve Orifice Area < 4 cm2